Zymeworks Inc. Stock Analysis & AI Score
Zymeworks Inc. (ZYME) has an ST Score of 49.1 (C+), driven by its Momentum (A-) and held back by its Financial Strength (C). Analysts rate it Buy with a $41.00 price target (+52.9% upside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Zymeworks Inc. (ZYME) has an ST Score of 49.1 (C+), driven by its Momentum (A-) and held back by its Financial Strength (C). Analysts rate it Buy with a $41.00 price target (+52.9% upside).
- Strongest
- MomentumA-
- Weakest
- Financial StrengthC
All factor grades
- MomentumA-
- GrowthB
- ForecastB
- ProfitabilityC+
- ValuationC
- Financial StrengthC
- Piotroski2/9
Contact
ZYME stock: frequently asked questions
What is ZYME's ST Score?
Zymeworks Inc. (ZYME) has an ST Score of 49.1 (C+), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is ZYME a buy, hold, or sell?
Analysts rate ZYME a Buy, with a price target of $41.00 (+52.9% vs the current price). Our ST Score grades it C+ (49.1/100). The ST Score is a data-driven signal, not a recommendation.
What are ZYME's factor grades?
Valuation C, Profitability C+, Financial Strength C, Momentum A-, Growth B, Forecast B.
What is ZYME's valuation grade?
Zymeworks Inc. (ZYME) earns a valuation grade of C, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is ZYME's growth grade?
Zymeworks Inc. (ZYME) earns a growth grade of B, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is ZYME's profitability grade?
Zymeworks Inc. (ZYME) earns a profitability grade of C+, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is ZYME's financial strength grade?
Zymeworks Inc. (ZYME) earns a financial strength grade of C, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for ZYME?
The average analyst price target for Zymeworks Inc. (ZYME) is $41.00 from 22 analysts, which is +52.9% versus the recent price of $26.81.
What is ZYME's Piotroski score?
Zymeworks Inc. (ZYME) has a Piotroski F-Score of 2 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.